GAMCO Investors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-121,277
Closed -$1.81M 928
2022
Q4
$1.81M Buy
+121,277
New +$1.68M 0.02% 496

GAMCO Investors's AVEO Position: Q1 2023 in Review

GAMCO Investors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 121,277 shares — an estimated $1.81M sold.

GAMCO Investors first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $1.81M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • GAMCO Investors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • GAMCO Investors sold 121,277 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.81M.
  • GAMCO Investors first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • GAMCO Investors's AVEO Pharmaceuticals, Inc. position peaked at $1.81M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on GAMCO Investors's 13F filing for Q1 2023, filed 12 May 2023.